Discounted and undiscounted total QALYs per treatment after a time horizon of 9 years
|
|
Discounted
|
Undiscounted
| | | | |
5-grass tablet
|
7.316
|
8.207
| | | | |
Allergoid mix
|
7.280
|
8.166
| | | | |
Symptomatic tx
|
7.235
|
8.116
| | | | |
Absolute and relative distribution of total undiscounted costs over individual cost components after 9 years
|
|
5-grass tablet
|
Allergoid mix
|
Symptomatic
|
|
Cost
|
Perc.
|
Cost
|
Perc.
|
Cost
|
Perc.
|
Visits (e.g. Dermatologist)
|
€ 267
|
15.0%
|
€ 299
|
22.9%
|
€ 227
|
62.4%
|
Injection/control
|
€ 4
|
0.2%
|
€ 69
|
5.2%
|
€ 0
|
0.0%
|
Diagnostics
|
€ 21
|
1.2%
|
€ 21
|
1.6%
|
€ 0
|
0.0%
|
Treatment costs
|
€ 1,381
|
77.7%
|
€ 809
|
61.8%
|
€ 0
|
0.0%
|
Other drugs costs
|
€ 82
|
4.6%
|
€ 86
|
6.6%
|
€ 102
|
28.1%
|
Asthma
|
€ 23
|
1.3%
|
€ 25
|
1.9%
|
€ 34
|
9.5%
|
Total
|
€ 1,778
|
100%
|
€ 1,308
|
100%
|
€ 363
|
100.0%
|
Discounted and undiscounted total costs per treatment and incremental costs after a time horizon of 9 years
|
|
Discounted
|
Undiscounted
| | |
|
Total
|
Inc. vs. 5-grass tablet
|
Total
|
Inc. vs. 5-grass tablet
| | |
5-grass tablet
|
€ 1,707
| |
€ 1,778
| | | |
Allergoid mix
|
€ 1,249
|
€ 458
|
€ 1,308
|
€ 470
| | |
Symptomatic tx
|
€ 322
|
€ 1,385
|
€ 363
|
€ 1,415
| | |
Discounted and undiscounted incremental costs and ICERs after a time horizon of 9 years
|
|
Inc. Costs
|
Inc. QALYs
|
ICER
| | | |
Discounted
| | | | | | |
5-grass tablet vs. Allergoid mix
|
€ 458
|
0.036
|
€ 12,593
| | | |
5-grass tablet vs. Symptomatic tx
|
€ 1,385
|
0.081
|
€ 17,007
| | | |
Undiscounted
| | | | | | |
5-grass tablet vs. Allergoid mix
|
€ 470
|
0.041
|
€ 11,576
| | | |
5-grass tablet vs. Symptomatic tx
|
€ 1,415
|
0.090
|
€ 15,635
| | | |